心血管病学进展2024,Vol.45Issue(8) :686-689.DOI:10.16806/j.cnki.issn.1004-3934.2024.08.004

重度主动脉瓣狭窄合并慢性肾脏病患者经导管主动脉瓣置换术研究进展

Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis Combined with Chronic Kidney Disease:A Study in Progress

陈道乾 何胜虎
心血管病学进展2024,Vol.45Issue(8) :686-689.DOI:10.16806/j.cnki.issn.1004-3934.2024.08.004

重度主动脉瓣狭窄合并慢性肾脏病患者经导管主动脉瓣置换术研究进展

Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis Combined with Chronic Kidney Disease:A Study in Progress

陈道乾 1何胜虎2
扫码查看

作者信息

  • 1. 扬州大学附属苏北人民医院,江苏扬州 225009
  • 2. 江苏省苏北人民医院心血管内科,江苏扬州 225001
  • 折叠

摘要

重度主动脉瓣狭窄(AS)与慢性肾脏病(CKD)二者关系密切,常共同存在,严重的CKD可能会加速AS的发展,而严重的AS可能会导致肾功能恶化.二者并存时患者生存率更差,经导管主动脉瓣置换术是解除重度AS症状的一线治疗方式,但在合并CKD(尤其终末期肾病)时的影响仍存在不确定性,这对临床治疗策略的选择带来了许多挑战,现对重度AS合并CKD患者经导管主动脉瓣置换术的研究进展做一综述.

Abstract

Severe aortic stenosis(AS)and chronic kidney disease(CKD)are closely related and often coexist.Severe CKD may accelerate the development of AS,while severe AS may lead to the deterioration of kidney function.Transcatheter aortic valve replacement is the first-line treatment for the relief of severe AS symptoms,but its impact on patients with CKD(especially end-stage renal disease)is still uncertain,which brings many challenges to the selection of clinical treatment strategies.This article reviews the research progress of transcatheter aortic valve replacement in patients with severe AS and CKD.

关键词

主动脉瓣狭窄/慢性肾脏病/经导管主动脉瓣置换术/终末期肾病

Key words

Aortic stenosis/Chronic kidney disease/Transcatheter aortic valve replacement/End-stage renal disease

引用本文复制引用

出版年

2024
心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
段落导航相关论文